HPV Genotypes and Vaccines in Uganda
Author Information
Author(s): Banura Cecily, Mirembe Florence M, Katahoire Anne R, Namujju Proscovia B, Mbonye Anthony K, Wabwire Fred M
Primary Institution: Makerere University College of Health Sciences
Hypothesis
What is the distribution of HPV genotypes in Uganda and how do current vaccines play a role in prevention?
Conclusion
HR-HPV infections are very common, especially among HIV positive individuals and young women, indicating a significant public health burden in Uganda.
Supporting Evidence
- HPV 16 and 18 are the most common genotypes in invasive cervical cancer cases.
- HIV positive women had a higher prevalence of HR-HPV infections.
- Vaccines currently available only protect against a few HPV types.
Takeaway
Many people in Uganda have a virus called HPV, which can cause cancer, especially in women. Vaccines can help, but they only protect against some types of the virus.
Methodology
A systematic review of 20 studies on HPV prevalence and genotypes in Uganda, using electronic databases to find peer-reviewed articles.
Potential Biases
Differences in HPV detection methods and sample collection could introduce bias.
Limitations
Variability in study populations, laboratory methods, and HPV genotypes detected may affect comparisons.
Participant Demographics
Included HIV positive and negative women, young women, and men aged 15-49.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI: 87.6-96.4
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website